Table 4.
Risk of renal cell carcinoma as estimated by mtDNA content*
mtDNA copy number | Case patients, No. (%) | Control subjects, No. (%) | Adjusted OR† (CI) |
By median‡ | |||
≥1.219 | 102 (39) | 138 (49) | 1.0 (reference) |
<1.219 | 158 (61) | 143 (51) | 1.53 (1.07 to 2.19) |
By spline modeling cutoff points | |||
≥1.216 | 102 (39) | 143 (51) | 1.0 (reference) |
0.814–1.215 | 123 (47) | 125 (44) | 1.43 (0.98 to 2.07) |
<0.814 | 35 (14) | 13 (5) | 4.15 (2.03 to 8.48) |
P for trend <.001 |
mtDNA = mitochondrial DNA; OR = odds ratio; CI = confidence interval.
Odds ratios were adjusted by age, sex, smoking status, hypertension history, and body mass index. The trend in odds ratios was tested by use of the test for linear trend. All statistical tests were two-sided.
Median is based on levels in control subjects.